Looking forward to welcoming you to ESCMID Global 2024, taking place live onsite in Barcelona, Spain and online through the Online Platform on 27 - 30 April 2024! We have an exceptional congress lined up for you.

Don’t miss the ESCMID “think tank” symposium on the importance of diagnostics in AMR on Friday 26 April 14:00 - 15:00 CEST, followed by the ESCMID-GLG high level event on forging partnership between science and policy to tackle AMR.

Science & Research

Get to know more about our excellent Study Groups, specialised in a wide range of CM/ID topics and open to all active ESCMID members, regardless of expertise or position.

The GLG report calls for improving new and existing financial commitments, the formation of an Independent Panel on Evidence for Action against AMR by 2025, strengthen country level AMR structures including data and surveillance programs, implement new strategies to prevent infections including IPC, WASH, and vaccination to ensure equitable access to antimicrobials and diagnostics.

The GLG also proposes specific global targets in humans to catalyse action at the national level to reduce global deaths caused by bacterial AMR by 10 % and access group antibiotics comprise at least 80 % of overall human antibiotic consumption all by 2030.

Read the full report here.

Education

The management of infections and sepsis in the immunocompromised host is challenging in many ways: delayed diagnosis, atypical presentation, metabolic changes, adjuvant therapies, severe prognosis, and end-of-life decisions. There is scarce information in the literature about the presentation and outcomes of sepsis in immunocompromised oncology patients with personalized management. Join us in Antalya for this new postgraduate course.

The new call for the ECDC Observership is open until 15 May 2024. The observership period is set for 14 - 18 October 2024. A group of 20 observers are offered a 5-day programme at the European Centre for Disease Prevention and Control (ECDC) in Solna, Stockholm County, Sweden.

Congress & Events

To honour these two critical WHO awareness campaigns, catch-up on the latest developments in malaria and immunisation research by following these sessions at ESCMID Global:

• Keynote lecture: Innovations in diagnosis, treatment and prevention of malaria, Hall A, 28 April 2024, 11:00 - 12:00
• New approaches for malaria screening, management and prevention, Hall E, 30 April 2024, 08:30 - 10:30
• Vaccine preventable diseases in the immunocompromised host: new developments, Hall C, 27 April 2024, 13:30 - 14:30
• Exploring frontiers: cutting-edge vaccines in development for a healthier tomorrow, Hall E, 28 April 2024, 16:15 - 17:15

Guidelines & Journals

The ESCMID Guidelines Subcommittee invites ESCMID members and ESCMID Study Groups to submit proposals for clinical practice guidelines projects in the following topics:

• Infection control and ICU standard procedures to reduce VAP
• Diagnosis and treatment of endovascular graft infections
• Diagnosis and treatment of Q fever

Topics for guidelines are here intended as broad areas, where the applicant is expected to propose scope and focus, balancing feasibility and comprehensiveness.

Deadline for submitting proposal is 12 May 2024.

The Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis

The fourth annual Infectious Diseases (ID) Pharmacists Day will be held on Wednesday, May 22 2024. This day recognises the importance of ID pharmacists and the contributions they make to patient care